These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 11938319

  • 1. [Cellular aspect of neuroinflammation in Guillain-Barré syndrome: a key to a new therapeutic option?].
    Créange A, Sharshar T, Raphaël JC, Gherardi R.
    Rev Neurol (Paris); 2002 Jan; 158(1):15-27. PubMed ID: 11938319
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cellular immunity in inflammatory autoimmune neuropathies.
    Mäurer M, Toyka KV, Gold R.
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S7-15. PubMed ID: 12690655
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
    Nicoletti F, Créange A, Orlikowski D, Bolgert F, Mangano K, Metz C, Di Marco R, Al Abed Y.
    J Neuroimmunol; 2005 Nov; 168(1-2):168-74. PubMed ID: 16171874
    [Abstract] [Full Text] [Related]

  • 8. [Guillain-Barré syndrome and acute disseminated encephalomyelitis (ADEM)].
    Hamaguchi K.
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1301-7. PubMed ID: 9128388
    [Abstract] [Full Text] [Related]

  • 9. [Guillain-Barre syndrome: etiology and pathogenesis].
    Avila-Funes JA, Mariona-Montero VA, Melano-Carranza E.
    Rev Invest Clin; 2002 Dec; 54(4):357-63. PubMed ID: 12415961
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. gamma delta T cells infiltrating sensory nerve biopsies from patients with inflammatory neuropathy.
    Winer J, Hughes S, Cooper J, Ben-Smith A, Savage C.
    J Neurol; 2002 May; 249(5):616-21. PubMed ID: 12021953
    [Abstract] [Full Text] [Related]

  • 16. Guillain-Barré syndrome: an update.
    Vucic S, Kiernan MC, Cornblath DR.
    J Clin Neurosci; 2009 Jun; 16(6):733-41. PubMed ID: 19356935
    [Abstract] [Full Text] [Related]

  • 17. Guillain-Barré syndrome during treatment with interferon alpha for hepatitis B.
    Boz C, Ozmenoglu M, Aktoz G, Velioglu S, Alioglu Z.
    J Clin Neurosci; 2004 Jun; 11(5):523-5. PubMed ID: 15177399
    [Abstract] [Full Text] [Related]

  • 18. Can IFN-γ be a therapeutic target in Guillain-Barré syndrome?
    Zhang HL, Wu L, Wu X, Zhu J.
    Expert Opin Ther Targets; 2014 Apr; 18(4):355-63. PubMed ID: 24479493
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.